Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Cost effectiveness analysis of PD-L1 testing in NSCLC - IVD vs LDT Jason Hurwitz, BA, MA, Phd; Shannon Vaffis, MPH, Phd; Amy Grizzle, BA, Pharm D This webinar will share compelling research that evaluated the cost-effectiveness of PD-L1 testing with an in vitro diagnostic (IVD) compared to a lab... 5 months ago | 45 mins The Dangers of Using a Laboratory-Developed Test as a Companion Diagnostic Keith Miller, FIBMS The Dangers of Using a Laboratory-Developed Test as a Companion Diagnostic presented by Keith Miller, FIBMS, Director, UK National External Quality As... 4 years ago | 25 mins The dangers of using a laboratory developed test as a companion diagnostic Keith Miller, FIBMS, Director, UKNEQAS-ICC&ISH Companion diagnostic tests are most commonly used to determine patient eligibility for specific therapies and are designed to ensure the therapy is ad... 7 years ago | 51 mins Molecular diagnostics in pediatric oncology Dr. Bastiaan Tops In this webinar, industry thought leader Dr. Bastiaan Tops will share his diagnostic laboratory's recent accomplishments in precision medicine at a na... 10 months ago | 58 mins Predictive assays: Analytic validation, clinical validation and clinical utility Krista Acosta, Nicole Schechter, PSM, PMP, Al Yates, PhD Predictive assays are a key element of personalized healthcare because these assays aid physicians in selecting individuals who are most likely or lea... 7 years ago | 55 mins Do Extractable Protocols Truly Help- An End User Perspective Ekta Mahajan, Genentech/Roche and Dr. Saskia Haehn, Laboratory Manager for E & L at Merck KGaA, Darmstadt Germany Presented by Ekta Mahajan, Technical Regulatory Program Director at Genentech Extractables and their perceived impact on product and patients continu... 4 years ago | 48 mins
